Categories

OEM Manufacturer for Procter & Gamble and Johnson & Johnson Sees Net Profit Surge 296.97%!

On April 9, Tongling Jieya Biotechnology Co., Ltd. (hereinafter referred to as “Jieya Shares”) released its 2025 annual report. The report showed that the company achieved total revenue of RMB 772 million, up 41.02% year-on-year, while net profit reached RMB 77.2698 million, representing a year-on-year increase of 296.97%. According to an analysis of Jieya Shares’ financial reports over the past four years, 2025 marked the company’s return to profitability after three consecutive years of declining performance.

Public information shows that Jieya Shares was established in 1999 and is a professional manufacturer specializing in the R&D, production, and sales of wet wipe products. The company was listed on the ChiNext board of the Shenzhen Stock Exchange in 2021. Currently, Jieya Shares mainly operates under ODM/OEM models, manufacturing wet wipes and facial mask products for well-known companies including Woolworths, Johnson & Johnson, Procter & Gamble, Reckitt, and The Clorox Company, while also producing and selling a limited number of self-owned brand products.

By business segment, the company’s other daily-use chemical products manufacturing business generated revenue of RMB 763 million, up 41.41% year-on-year, while other businesses contributed RMB 9.19 million, up 14.50%.

By product category, wet wipe products generated revenue of RMB 675 million, up 36.28% year-on-year; facial mask products recorded revenue of RMB 73.76 million, up 79.45%; and personal care products generated revenue of RMB 13.86 million, surging 381.92%.

By region, domestic revenue reached RMB 252 million, down 11.84% year-on-year, while overseas revenue climbed to RMB 520 million, representing a 99% increase.

Notably, in January 2023, Jieya Shares and Chuangjian Medical jointly established Anhui Jiechuang Medical Devices Co., Ltd., officially entering the recombinant collagen sector. In August 2025, Jieya Shares acquired the remaining 48% stake in Anhui Jiechuang Medical Devices Co., Ltd. previously held by Chuangjian Medical, making the company a wholly owned subsidiary of Jieya Shares.

In its annual report, Jieya Shares stated that it is accelerating its transformation from a traditional contract manufacturer into a professional ODM supply chain provider. The company is focusing on building core ODM supply chain capabilities, enhancing marketing efficiency and market expansion capabilities, and steadily advancing its global expansion strategy.

Facebook
Twitter
LinkedIn
Pinterest

Leave a Reply

Beauty News

Industry News, Broadcast and Breakings

Industry Stats

In-depth Statistics from all aspects to dig out the sales, up and downs.

Consumer Research

Exclusive service to survey numerous consumers across the country and get the best expected results

Brand Analysis

Examine and analyse a brand in details to conclude a report showcasing the desired information

Niche Market Research

Study into the niche product market, producing whitepaper helpping business to understand the potential, development of a product and make decisions.

 

Retail / Distributor Finder

Help brand distribute in China.

Cosmetics/ Makeup Compliance

Help make your product legal in China

OEM/ODM Manufacturers

Know what's trending or find the best possible material / ingredient / product supplier

Scroll to Top

Discover more from chaileedo

Subscribe now to keep reading and get access to the full archive.

Continue reading

Subscribe Now

Be the first to know about our latest news and market analysis. Sign up now to get all the beauty news you need!

Subscribe Yearly Member to Read More